{Reference Type}: Editorial
{Title}: The interferon story continues: EORTC CLTG study explores pegylated interferon α-2a's role in treating mycosis fungoides/Sézary syndrome.
{Author}: Stadler R;
{Journal}: Br J Dermatol
{Volume}: 191
{Issue}: 3
{Year}: 2024 Aug 14
{Factor}: 11.113
{DOI}: 10.1093/bjd/ljae188